Advanced Biomed Inc.
ADVB Healthcare Diagnostics & Research
Advanced Biomed Inc.’s revenue for fiscal 2026 (year ended June 2026) was $127,600.00. In the quarter to June 2026, EPS grew 54.8% and free cash flow fell 101.3%, each against the same quarter a year earlier.
Follow ADVB
A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.
| Jun '26 | Jun '25 | Jun '24 | |
|---|---|---|---|
Cash and Short Term Investments |
0.39 | 0.03 | 2.61 |
Other current assets |
— | 16.35 | — |
Total current assets |
13.75 | 22.38 | 3.05 |
Property, Plant, Equpment (Net) |
— | 0.33 | 0.52 |
Goodwill and Intangible Assets (Total) |
— | 0.12 | 0.12 |
Long Term Assets (Tax, Deferred) |
0.00 | — | — |
Total non-current assets |
0.00 | 0.48 | 1.41 |
Total Assets |
13.75 | 22.86 | 4.46 |
Accounts Payable |
1.47 | 0.78 | 2.67 |
Total current liabilities |
1.47 | 19.24 | 2.73 |
Non-current Liabilities (Other) |
— | 0.07 | — |
Total non-current liabilities |
— | 0.15 | 0.06 |
Total liabilities |
1.47 | 19.38 | 2.80 |
Additional Paid In Capital |
23.86 | 21.37 | 16.49 |
Common Stock (Net) |
0.00 | 0.00 | 0.02 |
Retained Earnings |
(12.56) | (19.23) | (15.97) |
Common Equity (Total) |
12.28 | 3.48 | 1.66 |
Shareholders Equity (Total) |
12.28 | 3.48 | 1.66 |
Shareholders Equity and Liabilities (Total) |
13.75 | 22.86 | 4.46 |
Shares (Common) |
1.65 | 1.08 | 1.00 |
Shareholders Equity (Tangible) |
12.28 | 3.48 | 1.54 |
Net Debt |
(0.39) | (0.03) | (2.61) |